Pelage’s PP405 novel topical reawakens dormant follicle stem cells, showing signs of terminal regrowth and fueling late-stage alopecia research.
Daniel Gil, PhD
Advertisement
Daniel Gil, PhD, is the Chief Executive Officer of Pelage.
Articles by Daniel Gil, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
Breakout Bulletin: July 13-July 17
4
New York Extends Nurse Practitioner Independent Practice Authority Through 2030
5